E.I.D. Parry’s division gets USFDA’s approval for Indian microalgae facility

08 May 2017 Evaluate

Parry Nutraceuticals, a division of E.I.D. Parry and part of the Murugappa Group has received the U.S. Food and Drug Administration (USFDA) approval for its Indian facility for organic microalgae cultivation and processing. The fully organic, 130 acres - 600 TPA facility, located in Oonaiyur, Pudukottai district, Tamil Nadu, has received the Establishment Inspection Report (EIR) from the USFDA following an inspection of the facility in July 2016.

Parry Nutraceuticals is also stepping up its new product development efforts to meet increasing customer demand for value-added products based on microalgae.

Parry Nutraceuticals has more than 2 decades of experience in cultivation and processing of microalgae-based nutraceuticals including Organic Spirulina, a recognised dietary supplement with high protein content, Astaxanthin, a powerful antioxidant, Organic Chlorella, which helps in detoxification & healthy ageing and other Phytochemicals.

E.I.D. Parry is a significant player in Sugar with interests in promising areas of Bio Pesticides and Nutraceuticals. The company also has a significant presence in Farm Inputs business through its subsidiary, Coromandel International.

E.I.D. Parry (I) Share Price

812.00 14.05 (1.76%)
31-Oct-2024 16:01 View Price Chart
Peers
Company Name CMP
Shree Renuka Sugar 43.19
Bajaj Hindusthan Sug 34.82
Balrampur Chini Mill 627.35
Triveni Engg. & Inds 416.00
Dalmia Bharat Sugar 460.50
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.